Analysts usually use two distinct methods in valuing companies, and they are the discounted cash flow method as well as the traditional price-to-earnings ratio (PER) method. The P/B method is well-known. The (P/B) method is an appropriate valuation method for companies in the financial industry such as banks or insurance companies. Balance sheet represents assets that are significantly liquid and are valued based on mark-to-market valuations, so it is deemed appropriate.
Typically,
banks or insurance companies are valued at a premium, as observed recently in
the sale of a 30.95% stake in Maybank Ageas Holdings Bhd by Ageas Insurance
International NV to Maybank at 1.98 times. The P/B method is also an
appropriate method to use during times of distress or when a company is
loss-making.
Source: https://www.investopedia.com
However, the P/B method has a fallacy, as the net asset value of a company is dependent on its dividend policy. Assuming two companies have a similar net asset value of RM500mil each and both companies can generate a net profit of RM70mil a year. A company’s dividend policy will have a significant impact on how the net asset value grows in the future.
Literature has also shown that there is a positive correlation between P/B and return on equity (RoE). Hence, companies like Public Bank and Maybank do trade at a premium to the overall sector averages due to higher RoEs. A company that pays out much of its earnings as dividends tends to have better RoEs.
There are no right or wrong answers when it comes to valuing a company based on a certain discount to its “fair value”, especially when it comes to the P/B method or, in the case of property companies, using the realisable net asset value (RNAV) method. The best approach to the appropriate discount is to use the historical trend in terms of the observable market price and the P/B or RNAV value. The difficulty lies when an analyst changes this discount and applies the discount arbitrarily. How does one justify changing a 30% discount to 20% or to 40% or 50% without quantifying why the change necessitates the different discounts?
In the era of tech, artificial intelligence (AI) and semiconductor booms, revenue, cashflows or even earnings multiplier has taken a quantum leap. Valuing some of these companies north of 30 times or 40 times PER is getting too common. A word of caution is in order, as any multiples beyond a certain threshold will be tough to justify if the earnings growth does not match. As a rule of thumb, a stock is only cheap if its future growth is at a higher rate than the PER multiple used to justify its valuation.
Based on the above examples, while one understands that valuation itself is an art and no two analysts will be valuing the same company based on the same valuation matrix, there must be justification as to why a valuation method is used and how the change in the company’s and industry’s fundamentals impact the valuation itself. In the case of high-growth companies, the PER multiple must be justified with the expected growth, as a company cannot be valued at a PER-to-growth multiple beyond 1.0 times as it is unrealistic. Distorted market valuation methods can hide a true fair value of a company, and analysts should not be chasing stocks, as markets and investors can be irrational.
It is more difficult if it’s a start-up and you rely on projections. It requires more work on assumptions and the DCF method may be more appropriate. Valuation, as said earlier, is an art, although many try to make it into a science. Ultimately, it is a willing-buyer-willing-seller basis. And the valuation report is a starting point for the final, negotiated price for an investment or divestment.
Reference:
Distorted valuation methods hide true value, Pankaj C. Kumar, The Star,
15 August 2026












